Gilead Sciences (GILD) Shares Outstanding (Diluted Average) (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) changed 0.4% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (changed 0.4% YoY), and the FY2025 full-year result was $1.3 billion, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $1.3 billion in Q1 2022 and bottomed at $1.2 billion in Q1 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $1.3 billion (2023), against an average of $1.3 billion.
• The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) slipped 1.11%; it then climbed 0.96% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.3 billion in 2022, then decreased by 0.32% to $1.3 billion in 2023, then slipped by 0.24% to $1.3 billion in 2024, then changed by 0.0% to $1.3 billion in 2025, then retreated by 0.08% to $1.3 billion in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison